Dopamine D3 receptor antagonists: a patent review (2007 – 2012)

Author： Micheli Fabrizio Heidbreder Christian

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.3, 2013-03, pp. : 363-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective dopamine D₃ receptor antagonists. A decade of progress: 1997 – 2007

By Micheli Fabrizio Heidbreder Christian

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 821-840

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 89-99

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 –– 2010)

By Malherbe Pari Ballard Theresa M Ratni Hassen

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 637-655

Informa Healthcare

Access to resources Recommend Favorite

AT1 antagonists: a patent review (2008 – 2012)

By Mavromoustakos Thomas Agelis George Durdagi Serdar

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1483-1494

Informa Healthcare

Access to resources Recommend Favorite

Selective dopamine D4 receptor antagonists

By Sanner M.A.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite